MedTrace Logo

Perioperative Salivary Alpha-amylase as a Predictor of Delirium After Lower Extremity Vascular Bypass Surgery

NCT06242275 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2025-06-25

No results posted yet for this study

Summary

The aim of this study is to evaluate the role of salivary Alpha-amylase as a predictor biomarker of POD in elderly patients undergoing limb bypass surgery.

Conditions

  • Salivary Alpha-amylase
  • Delirium
  • Lower Extremity
  • Vascular Bypass Surgery

Interventions

DIAGNOSTIC_TEST

Salivary Alpha-amylase

Saliva samples will be obtained using a saliva collection system and salivary Alpha-amylase (SAA) level will be measured preoperatively, immediately postoperative, at the end of the 1st, 2nd, and 3rd postoperative days. For sampling, the swab will be placed into the patient's mouth for 2-5min by a specially trained nurse. A minimum of 0.2mL of saliva will be needed as per the manufacturer's recommendations to saturate the swab.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-10
Primary Completion
2025-06-17
Completion
2025-06-19

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06242275 on ClinicalTrials.gov